Literature DB >> 192183

In vitro and in vivo inhibition of virus multiplicaton by microwave hyperthemia.

S Szmigielski, M Luczak, M Janiak, M Kobus, B Laskowska, E de Clercq, P de Somer.   

Abstract

The effect of microwave hyperthermia (41 degrees and 43 degrees C) on virus multiplication have been explored in vitro (HSV-1 infected primary rabbit kidney cultures) and in vivo (mice infected with HSV-1 or vaccinia). In vitro the cells were inoculated with HSV-1 and heated to 41 degrees or 43 degrees C either before or after infection. Virus yields were significantly decreased when the cells were exposed to hyperthemia within the first few hours after infection, while hyperthemia was without effect when applied before infection or with several hours delay after infection. In mice inoculated intranasally with HSV-1, mortality due to herpes encephalitis was significantly reduced upon daily exposure to microwave hyperthermia from the day of infection onward. In mice inoculated intravenously with vaccinia, a significant decrease in the number of specific tail lesions was observed if the animals were exposed to microwave hyperthermia within the first three days after infection, while irradiation prior to infection or delayed until several days after infection did not exhibit an appreciable effect. Our data suggest that microwave hyperthermia interferes directly with the virus multiplication cycle both in vitro and in vivo.

Entities:  

Mesh:

Year:  1977        PMID: 192183     DOI: 10.1007/bf01314848

Source DB:  PubMed          Journal:  Arch Virol        ISSN: 0304-8608            Impact factor:   2.574


  9 in total

Review 1.  Hyperthermia: potential as an anti-tumor agent.

Authors:  H D Suit; M Shwayder
Journal:  Cancer       Date:  1974-07       Impact factor: 6.860

Review 2.  Analysis of reported physiologic effects of microwave radiation.

Authors:  B D McLees; E D Finch
Journal:  Adv Biol Med Phys       Date:  1973

3.  [In vitro effect of hyperthermia on the incorporation rate of nucleic acid precursors in tumours and normal tissues].

Authors:  G P Wüst; K Norpoth; U Witting; W Oberwittler
Journal:  Z Krebsforsch Klin Onkol Cancer Res Clin Oncol       Date:  1973-05-07

4.  Investigations on the possibility of a thermic tumour therapy. I. Short-wave treatment of a transplanted isologous mouse mammary carcinoma.

Authors:  K Overgaard; J Overgaard
Journal:  Eur J Cancer       Date:  1972-02       Impact factor: 9.162

5.  Effects of temperature on the kinetics of the mitotic cycle of mammalian cells in culture.

Authors:  J E Sisken; L Morasca; S Kibby
Journal:  Exp Cell Res       Date:  1965-08       Impact factor: 3.905

6.  Effect of microwaves on cell function and virus replication in cell cultures irradiated in vitro.

Authors:  S Szmigielski; M Luczak; M Wiranowska
Journal:  Ann N Y Acad Sci       Date:  1975-02-28       Impact factor: 5.691

7.  Effect of cytosine, arabinoside, iododeoxyuridine, ethyldeoxyuridine, thiocyanatodeoxyuridine, and ribavirin on tail lesion formation in mice infected with vaccinia virus.

Authors:  E De Clercq; M Luczak; D Shugar; P F Torrence; J A Waters; B Witkop
Journal:  Proc Soc Exp Biol Med       Date:  1976-03

8.  Intranasal challenge of mice with herpes simplex virus: an experimental model for evaluation of the efficacy of antiviral drugs.

Authors:  E De Clercq; M Luczak
Journal:  J Infect Dis       Date:  1976-06       Impact factor: 5.226

9.  The selective inhibitory effect of hyperthermia on the metabolism and growth of malignant cells.

Authors:  D S Muckle; J A Dickson
Journal:  Br J Cancer       Date:  1971-12       Impact factor: 7.640

  9 in total
  2 in total

Review 1.  Temperature and host defense.

Authors:  N J Roberts
Journal:  Microbiol Rev       Date:  1979-06

2.  Comparison of intravenous versus intraperitoneal administration of oncolytic herpes simplex virus 1 for peritoneal carcinomatosis in mice.

Authors:  Y Kulu; J D Dorfman; D Kuruppu; B C Fuchs; J M Goodwin; T Fujii; T Kuroda; M Lanuti; K K Tanabe
Journal:  Cancer Gene Ther       Date:  2008-11-07       Impact factor: 5.987

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.